Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > This is just wonderful news from the vaccine side---

<< Previous

Bullboard Posts

Next >>

Comment by Oden6570on Feb 07, 2022 10:56am

501 Views

Post# 34404680

RE:RE:This is just wonderful news from the vaccine side---

enriquesuave wrote: A whole vaccine platform in the making. Awesome.
"Arkady Mandel, interim CEO and Chief Scientific Officer at Theralase, said the research also demonstrates that the Theralase platform is "extremely versatile", with an ability to be applicable to a wide range of enveloped viruses."

And as a result our value has substantially increased IMHO .

<< Previous

Bullboard Posts

Next >>

Rig Count Soars as Utilization Surpasses Industry Averages